BHVN (Biohaven Ltd.) Stock Market Reviews

crown

search

Read and share opinions on BHVN (Biohaven Ltd.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

BHVN

Biohaven Ltd.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Biohaven (BHVN): Assessing Valuation After $175 Million Stock Offering and FDA Setback
Nov 15, 2025
Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M
Nov 13, 2025
Biohaven Announces Pricing of $175 Million Public Offering of Common Shares
Nov 12, 2025
Biohaven Announces Proposed Public Offering of Common Shares
Nov 11, 2025
Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments
Nov 10, 2025
Biohaven Says FDA Recommends Meeting in Response Letter for Spinocerebellar Ataxia Treatment Application; Shares Down Pre-Bell
Nov 5, 2025
FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia
Nov 5, 2025

Reviews